Inflammation in Chronic Disease: Cause, Consequence, or Both?

GW relaunches Biomedical Cross-disciplinary Seminar Series
illustration of gears with medical symbols inside

Join us for the GW Biomedical Cross-disciplinary Seminar Series: Connecting Academic Research & Inquiry Across Disciplines. This annual series will explore a new cross-disciplinary topic each year. The goal is to promote networking and collaboration in translational health among researchers, health care providers, and policy makers from different disciplines to shift the paradigm—from seeking a cure to developing a strategy of prevention.  Learn more and register here.

Inflammation and specifically chronic inflammation are the primary pathophysiologic process in all chronic diseases, according to scientific consensus. Chronic diseases and chronic inflammatory diseases (CIDs) are predicted to increase to 49.2 percent in 2030. (1) CIDs will increase demand and cost of health care services while leading to reduced quality of life and death. (2) This has become increasingly clear during the SARS-CoV-2 pandemic, where CIDs have shown to increase risk for severe COVID-19 illness. (3) The 2020 seminar series will focus on both the treatment and prevention of CIDs. Due to the ongoing pandemic, the series is moving online.

This virtual series will run through September 2021. It is open to all and covers the following topics:

  • Cancer and inflammation
  • Genomics and inflammation
  • COVID-19
  • Bioinformatics and inflammation
  • Cardiometabolic disease and inflammation
  • Neuropsychiatric disease and inflammation
  • Precision medicine and inflammation
  • Treatment approaches and inflammation
  • One GW event

The series was organized by the GW School of Medicine and Health Sciences’ (SMHS) Department of Pharmacology & Physiology and the Office of Integrative Medicine and Health. The seminar series is supported by departmental funding and the generosity of Ellen J. LaBelle, MD `74, RESD '78, associate clinical professor of the Department of Psychiatry and Behavioral Sciences, and John Pan, MD '70, RESD '74, clinical professor, Department of Clinical Research and Leadership and founding medical director, Office of Integrative Medicine and Health.

For more information, contact co-organizer Leigh Frame, PhD, MHS, Program Director, Integrative Medicine, and Executive Director, Office of Integrative Medicine and Health, at leighframe@gwu.edu or 202-994-0184 or co-organizer Paul Marvar, PhD, associate professor, Department of Pharmacology and Physiology, pmarvar@gwu.edu or 202-994-5584. 

Go here to register for upcoming seminars.

SOURCE

RAND Corporation. Projections of Chronic Illness Prevalence and Cost Inflation. https://www.fightchronicdisease.org/sites/default/files/docs/GrowingCrisisofChronicDiseaseintheUSfactsheet_81009.pdf Accessed December 5, 2019.

Straub RH, Schradin C. Chronic Inflammatory systemic diseases: An evolutionary trade-off between acutely beneficial but chronically harmful programs. Evolution, Medicine, and Public Health. 2016; 2016(1): 37–51.

Certain Medical Conditions and Risk for Severe COVID-19 Illness | CDC Available online: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html (accessed on Aug 25, 2020).

Latest News

GW Integrative Medicine Programs faculty appointed to Influential NIH National Cancer Institute Editorial Board. 
GW Presenting 4 Posters at International Congress on Integrative Medicine & Health in April 2024.
New GW Resiliency and Well-being Center Study Also Identifies Factors that Protect Women Healthcare Professionals Against Harmful Stress.